Beginning in 1989, countries of the European Union and European Economic Area (EU/EEA) began introducing conjugate
Hib vaccination into their routine national immunization programs; most countries introduced the vaccine before the year 2000.
By 2006, when WHO recommended Hib vaccine in all routine infant immunization schedules, 108 countries, accounting for >55% of the world's children, had introduced routine
Hib vaccination (7).
* Limit Haemophilus influenzae b (Hib) to one dose for all children and adolescents with no previous history of
Hib vaccination.
The
Hib vaccination is not recommended for HIV-infected adults.
HibMenCY is safe and immunogenic and may be administered to infants to complete the routine
Hib vaccination series.
GSK said that MenHibrix was developed to align with the Centres for Disease Control and Prevention's recommended infant immunisation schedule for
Hib vaccination and to allow for vaccination against meningococcal groups C & Y without adding additional shots.
A study on anti-Hib seroprevalence in Sweden 5 and 15 years after the introduction of universal
Hib vaccination related to notifications of invasive disease.
Black et al (14) have estimated 31,607 deaths attributable to meningitis in India after taking into account cases currently prevented by the
Hib vaccination (Hib vaccine is available and used in India).
(1) In countries with routine
Hib vaccination, Hib is no longer the most important cause of bacterial meningitis in children.
By 2004, a total of 134 of 165 developing countries had introduced hepatitis B vaccination into their national immunization schedules, and 63 had introduced
Hib vaccination; however, coverage levels have stagnated or remain suboptimal in many countries.
Even though there was a
Hib vaccination shortage at the time, none of the children were unvaccinated due to the shortage.